(Q46897460)

English

Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis

scientific article published in January 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16417526

Pharmacodynamic and pharmacokinetic characterization of interactions between levetiracetam and numerous antiepileptic drugs in the mouse maximal electroshock seizure model: an isobolographic analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16417526

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

Jarogniew Łuszczki

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16417526

Stanisław Jerzy Czuczwar

7

object named as

Stanislaw J Czuczwar

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16417526

3

object named as

Piotr Czuczwar

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16417526

Anna Cioczek-Czuczwar

4

object named as

Anna Cioczek-Czuczwar

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16417526

Neville Ratnaraj

5

object named as

Neville Ratnaraj

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16417526

author name string

Marta M Andres

2

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16417526

Philip N Patsalos

6

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16417526

publication date

1 January 2006

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16417526

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16417526

47

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16417526

1

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16417526

10-20

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16417526

Revisiting the concept of identifiable neurons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Levetiracetam as add-on therapy in generalised epilepsies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Levetiracetam treatment of idiopathic generalised epilepsy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

A pilot tolerability and efficacy study of levetiracetam in patients with chronic myoclonus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Efficacy and tolerability of levetiracetam in children aged 10 years and younger: a clinical experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Levetiracetam monotherapy for elderly patients with epilepsy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Levetiracetam monotherapy for adults with localization-related epilepsy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Levetiracetam monotherapy for newly diagnosed epilepsy patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Reduction of voltage-operated potassium currents by levetiracetam: a novel antiepileptic mechanism of action?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Selective blockade of N-type calcium channels by levetiracetam

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Intracellular calcium increase in epileptiform activity: modulation by levetiracetam and lamotrigine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Levetiracetam does not modulate neuronal voltage-gated Na+ and T-type Ca2+ currents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

The anti-epileptic drug levetiracetam reverses the inhibition by negative allosteric modulators of neuronal GABA- and glycine-gated currents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Which animal models should be used in the search for new antiepileptic drugs? A proposal based on experimental and clinical considerations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

ucb L059, a novel anti-convulsant drug: pharmacological profile in animals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Early identification of refractory epilepsy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Clinically important drug interactions in epilepsy: interactions between antiepileptic drugs and other drugs

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

The importance of drug interactions in epilepsy therapy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Selection of antiepileptic drug polytherapy based on mechanisms of action: the evidence reviewed

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Pharmacodynamic and pharmacokinetic interaction studies of loreclezole with felbamate, lamotrigine, topiramate, and oxcarbazepine in the mouse maximal electroshock seizure model

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Pharmacodynamic interaction studies with topiramate in the pentylenetetrazol and maximal electroshock seizure models

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Anticonvulsant effects of levetiracetam and levetiracetam-diazepam combinations in experimental status epilepticus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Carbamazepine toxicity during combination therapy with levetiracetam: a pharmacodynamic interaction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Efficacy and safety of levetiracetam in children with partial seizures: an open-label trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Interactions of lamotrigine with topiramate and first-generation antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Preclinical profile of combinations of some second-generation antiepileptic drugs: an isobolographic analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Isobolographic and subthreshold methods in the detection of interactions between oxcarbazepine and conventional antiepileptics--a comparative study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Modulation of morphine antinociception by peripheral [Leu5]enkephalin: a synergistic interaction.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Effect of gabapentin on the anticonvulsant activity of antiepileptic drugs against electroconvulsions in mice: an isobolographic analysis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Isobolographic profile of interactions between tiagabine and gabapentin: a preclinical study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Benzodiazepine impairs and beta-carboline enhances performance in learning and memory tasks

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Tiagabine synergistically interacts with gabapentin in the electroconvulsive threshold test in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Pharmacological and behavioral characteristics of interactions between vigabatrin and conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice: an isobolographic analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Cellular actions of topiramate: blockade of kainate-evoked inward currents in cultured hippocampal neurons

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Levetiracetam selectively potentiates the acute neurotoxic effects of topiramate and carbamazepine in the rotarod test in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Levetiracetam for people with mental retardation and refractory epilepsy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Pharmacokinetic profile of levetiracetam: toward ideal characteristics

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Serum concentrations of Levetiracetam in epileptic patients: the influence of dose and co-medication

1 reference

https://api.crossref.org/works/10.1111%2FJ.1528-1167.2006.00364.X

21 January 2018

Identifiers

10.1111/J.1528-1167.2006.00364.X

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16417526

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 December 2017

http://europepmc.org/abstract/MED/16417526

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46897460&oldid=2144075887"